Back To Schedule
Monday, September 19 • 11:45am - 12:15pm
The Time is Now: How Scaling Biotechs can Grow in a Difficult Economy

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Since the 2008 Great Recession, the life sciences market has seen record infusion of venture capital (VC) dollars in early-stage, scaling biotech firms. And while VC has pulled back somewhat over the last couple of years as companies brace for recession, investing remains strong—the year-to-date VC totals for 2022 already exceed 2019 levels.

So with so many of them poised to begin growing, these biotechs need to navigate the challenges and opportunities that come with scaling in a difficult economic environment—especially taking into consideration their real estate infrastructure and facilities. In this session, you’ll learn how scaling life sciences firms can think strategically about their office, lab and manufacturing spaces—in a way that conserves capital while helping to rapidly boost productivity and accelerate scientific development.

avatar for David Lucchino

David Lucchino

Co-founder, President and CEO, Frequency Therapeutics
David is a life sciences CEO and entrepreneur with nearly two decades of executive leadership experience, having played an integral role in launching, building and operating several successful companies in both the biotech and medical device industries. Over the course of his career... Read More →
avatar for Bob Coughlin

Bob Coughlin

Managing Director, Life Sciences, JLL
Mr. Coughlin is a Managing Director at JLL and is the New England’s Life Science Practice Group lead. He specializes in the representation of lab, GMP manufacturing and technology space. Robert delivers creative solutions that align real estate strategies with scientific business... Read More →

Monday September 19, 2022 11:45am - 12:15pm EDT